868 - Skin Cancer: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what plans the NHS has to use the drug T-Vec for the treatment of skin cancer.

George Freeman

Talimogene laherparepvec (T-Vec) is still undergoing clinical trials and has not yet been licensed for the treatment of malignant melanoma by the regulatory authorities in either the United States or the European Union.

The Department has made no specfic assessment of research findings into its use to treat melanoma.

824 - Cancer: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what discussions he has had with his EU counterparts on reviewing EU legislation on access to cancer drugs for children.

George Freeman

The European Union Regulation on Paediatric Medicines has been successful in increasing the number of medicines authorised to treat diseases that affect children and it has led to an overall increase in the number of paediatric clinical trials in the United Kingdom and across Europe in many therapeutic areas, including oncology.

706 - Drugs (Answered)

Mrs Sharon Hodgson
To ask the Secretary of State for Health, what steps his Department is taking to ensure that patients benefit from scientific research into personalised medicines.

George Freeman

705 - Ovarian Cancer: Drugs (Answered)

Mrs Sharon Hodgson
To ask the Secretary of State for Health, what steps his Department is taking to offer personalised medicines to women with BRCA-mutated ovarian cancer with limited treatment options.

George Freeman

NHS England provides BRCA testing services for women at high risk of breast and ovarian cancer.

704 - Ovarian Cancer: Drugs (Answered)

Mrs Sharon Hodgson
To ask the Secretary of State for Health, what assessment his Department has made of the effects of the decision by the Cancer Drugs Fund not to fund olaparib for patients with BRCA-mutated ovarian cancer.

George Freeman

1477 - Office for Life Sciences (Answered)

Mr Iain Wright
To ask the Secretary of State for Business, Innovation and Skills, what his policy is on future government support for the Office for Life Sciences.

George Freeman

581 - Medical Records: Leeds (Answered)

Mr Roger Godsiff
To ask the Secretary of State for Health, whether the three clinical commissioning groups in Leeds not included in the Schedule to the draft directions on care.data submitted to NHS England for approval will be included in the pathfinder process.

George Freeman

The directions will be updated to include Leeds pathfinder practices, at the appropriate time, once all the participating practices have been confirmed.

381 - NHS England (Answered)

John Glen
To ask the Secretary of State for Health, what the (a) names and (b) positions are of all members of NHS England's (i) Clinical Priorities Advisory Group, (ii) Specialised Commissioning Oversight Group and (iii) Specialised Commissioning Committee.

George Freeman

A list of the names and positons of all members of NHS England’s Clinical Priorities Advisory Group, Specialised Commissioning Oversight Group and Specialised Commissioning Committee has been attached to this answer.

57 - Paracetamol: Children (Answered)

Jim Shannon
To ask the Secretary of State for Health, what steps he is taking to encourage a reduction in the use of paracetamol by children.

George Freeman

75 - Kisspeptin (Answered)

Jim Shannon
To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges about the use of kisspeptin to treat (a) infertility and (b) diabetes.

George Freeman

There have been no discussions between my Rt. hon. Friend the Secretary of State for Health and the Royal Colleges about the use of Kisspeptin to treat infertility or diabetes.

Pages